Libertyville, IL, United States of America

Sheela A Thomas

This inventor holds 16 USPTO granted patents and 1 published patent application, plus 6 CIPO patents and 5 EPO patents, primarily in PARP Inhibitors. Top assignees: Abbott Laboratories Corporation, Abbvie Inc., Other. Active years: 1991-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sheela A Thomas. Retrieved from https://idiyas.com/inventor/sheela-a-thomas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 87.5

 


Average Co-Inventor Count = 7.5

ph-index = 8

Forward Citations = 378(Granted Patents)


Location History:

  • Vernon Hills, IL (US) (1991 - 1997)
  • Vernon Hills, IN (1998)
  • Libertyville, IL (US) (2004 - 2014)

Company Filing History:


Years Active: 1991-2014

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
PARP Inhibitors
Apoptosis Promoters
1H-Benzimidazole
N-Acylsulfonamide
Biaryl Carboxylic Acid
Kinase Inhibitors
Dopaminergic Compounds
Amino-Lipopetide
Carboxamides
Substituted Compounds
Cancer Therapy
Pharmaceuticals
16 patents (USPTO):Explore Patents

Title: The Innovative Mind of Sheela A. Thomas: A Leader in PARP Inhibition

Introduction: Sheela A. Thomas, based in Libertyville, IL, is an accomplished inventor renowned for her significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 16 patents, her inventions have made a profound impact on PARP inhibition, offering potential treatments for various diseases and disorders associated with this enzyme.

Latest Patents: Among her latest innovations, Sheela has developed compounds such as 1H-benzimidazole-4-carboxamides that are substituted with phenyl at the 2-position. These compounds serve as potent PARP inhibitors, providing new avenues for treatment. The patents disclose pharmaceutical compositions comprising these compounds, alongside methods for treatment and strategies for inhibiting the PARP enzyme, all aimed at advancing therapy options for critical health issues.

Career Highlights: Throughout her career, Sheela has been associated with prestigious companies such as Abbott Laboratories Corporation and AbbVie Inc., where she has applied her expertise in drug development and innovation. Her work in these organizations reflects her dedication to advancing medical science and enhancing patient care.

Collaborations: Sheela's professional journey is marked by collaborative efforts with esteemed colleagues, including Vincent L. Giranda and Gui-Dong Zhu. These partnerships have fostered innovative research, allowing her to push the boundaries of what's possible in pharmaceutical interventions.

Conclusion: Sheela A. Thomas stands out as a leading inventor in the pharmaceutical sector, with her patents providing critical advancements in PARP inhibition. Her dedication to her work and collaborations has not only contributed to the field but also emphasizes the importance of innovation in tackling complex health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…